Regeneron (NASDAQ:REGN) announced Tuesday that Eylea HD, the high-dose version of its blockbuster eye care medication Eylea ...

So a retinal vein occlusion is when there is an occlusion ... it to my patients is that if we were to look in the back of the eye, there is a structure called the retina. That's sort of like ...

Eylea HD and Eylea, which are administered by injection into the eye, contain the same ingredient ... FDA-approved anti-VEGF therapies for retinal vein occlusion require monthly dosing, which ...

Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for ...

Regeneron's EYLEA HD met key goals in the Phase 3 QUASAR trial for macular edema after retinal vein occlusion, with FDA ...

Regeneron's phase III study evaluating Eylea HD against stand-of-care Eylea treatment meets the primary endpoint of ...

Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "Retinal Vein Occlusion Treatment Market by Treatment Type (Anti-VEGF Injection, Corticosteroid Treatment, Laser Therapy), Age Group (40-60, Above 60, ...

and retinal vein occlusion (RVO) The ready-to-use Vabysmo PFS is co-packaged with the only CE-marked needle specifically designed for intravitreal injection Basel, 13 December 2024– Roche (SIX: RO, ...